Teleflex (TFX) Research & Development (2009 - 2026)
Teleflex's (TFX) quarterly Research & Development came in at $44.4 million in Q1 2026, up 75.47% YoY from $25.3 million in Q1 2025, and up 251.49% on a QoQ basis from $12.6 million in Q4 2025.
Teleflex (TFX) Research & Development (2009 - 2026) Analysis & Trends
Teleflex (TFX) has 18 years of Research & Development data on file, last reported at $44.4 million in Q1 2026.
- Quarterly Research & Development rose 75.47% year-over-year to $44.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $152.8 million (up 57.46% YoY) and the FY2025 annual result came in at $144.8 million, up 32.8% from the prior year.
- Research & Development grew to $44.4 million in Q1 2026, from $12.6 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $57.2 million in Q3 2025 to a low of -$8.1 million in Q4 2024.
- A 5-year average of $32.6 million and a median of $37.8 million in 2022 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2023 — Research & Development slumped 111.38% — and 2025, when it surged 255.94%.
- Tracing TFX's Research & Development over 5 years: stood at $42.8 million in 2022, then tumbled by 111.38% to -$4.9 million in 2023, then slumped by 66.42% to -$8.1 million in 2024, then surged by 255.94% to $12.6 million in 2025, then jumped by 251.49% to $44.4 million in 2026.
- The last three Research & Development figures came in at $44.4 million (Q1 2026), $12.6 million (Q4 2025), and $57.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 370.60 Mn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 258.00 Mn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 663.00 Mn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 105.73 Mn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 19.70 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 178.00 Mn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 42.50 Mn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 129.00 Mn |
| 10 | Teleflex | 5.89 Bn | 5.59 Bn | 331.71 Mn | 45.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 45.12 Mn |
| Mar 31, 2026 | 44.39 Mn |
| Dec 31, 2025 | 12.63 Mn |
| Sep 28, 2025 | 57.23 Mn |
| Jun 29, 2025 | 38.52 Mn |
| Mar 30, 2025 | 25.30 Mn |
| Dec 31, 2024 | -8.10 Mn |
| Sep 29, 2024 | 38.73 Mn |
| Jun 30, 2024 | 41.09 Mn |
| Mar 31, 2024 | 37.30 Mn |
| Dec 31, 2023 | -4.87 Mn |
| Oct 1, 2023 | 37.58 Mn |
| Jul 2, 2023 | 39.45 Mn |
| Apr 2, 2023 | 41.47 Mn |
| Dec 31, 2022 | 42.76 Mn |
| Sep 25, 2022 | 37.77 Mn |
| Jun 26, 2022 | 36.93 Mn |
| Mar 27, 2022 | 36.36 Mn |
| Dec 31, 2021 | 35.80 Mn |
| Sep 26, 2021 | 31.82 Mn |